000518 Stock Overview
Engages in the pharmaceutical business in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Jiangsu Sihuan Bioengineering Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.53 |
| 52 Week High | CN¥3.99 |
| 52 Week Low | CN¥1.72 |
| Beta | 0.42 |
| 1 Month Change | -31.81% |
| 3 Month Change | 5.42% |
| 1 Year Change | -24.25% |
| 3 Year Change | -31.44% |
| 5 Year Change | -30.11% |
| Change since IPO | 298.17% |
Recent News & Updates
Risks Still Elevated At These Prices As Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) Shares Dive 25%
Dec 30
What Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) 33% Share Price Gain Is Not Telling You
Oct 28Recent updates
Risks Still Elevated At These Prices As Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) Shares Dive 25%
Dec 30What Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) 33% Share Price Gain Is Not Telling You
Oct 28More Unpleasant Surprises Could Be In Store For Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) Shares After Tumbling 26%
Jun 11More Unpleasant Surprises Could Be In Store For Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) Shares After Tumbling 26%
Apr 17Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) Investors Are Less Pessimistic Than Expected
Feb 26Shareholder Returns
| 000518 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -18.9% | -0.8% | 1.0% |
| 1Y | -24.3% | -22.3% | 8.2% |
Return vs Industry: 000518 underperformed the CN Biotechs industry which returned -22.3% over the past year.
Return vs Market: 000518 underperformed the CN Market which returned 8.2% over the past year.
Price Volatility
| 000518 volatility | |
|---|---|
| 000518 Average Weekly Movement | 11.5% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CN Market | 12.2% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 000518's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 000518's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 282 | Yu Guo | www.000518shsw.com/shsw |
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusen, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass; Xinde Lusheng; Xin Lisheng; and Ring BO. It also engages in breeding and sales of flowers and seedlings; and landscaping projects.
Jiangsu Sihuan Bioengineering Co., Ltd Fundamentals Summary
| 000518 fundamental statistics | |
|---|---|
| Market cap | CN¥2.69b |
| Earnings (TTM) | -CN¥46.57m |
| Revenue (TTM) | CN¥211.48m |
12.3x
P/S Ratio-55.9x
P/E RatioIs 000518 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000518 income statement (TTM) | |
|---|---|
| Revenue | CN¥211.48m |
| Cost of Revenue | CN¥84.47m |
| Gross Profit | CN¥127.01m |
| Other Expenses | CN¥173.58m |
| Earnings | -CN¥46.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.045 |
| Gross Margin | 60.06% |
| Net Profit Margin | -22.02% |
| Debt/Equity Ratio | 3.1% |
How did 000518 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 11:26 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Sihuan Bioengineering Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|